Baldwin J. A. (1979) Schizophrenia and physical disease. Psychological Medicine, 9, 611–618.
Basu S. & Dasgupta P. S. (2000) Role of dopamine in malignant tumour growth. Endocrine, 12, 237–241.
Breslow N. E. & Day N. E. (1987) Statistical Methods in Cancer Research, vol. II. The Design and Analysis of Cohort Studies. IARC Scientific Publication No. 82, pp. 103–115. Lyon: International Agency for Research in Cancer.
Carrillo J. A. & Benitez J. (1999) Are antipsychotic drugs potentially chemopreventive agents for cancer?
European Journal of Clinical Pharmacology, 55, 487–488.
Catts V. S. & Catts S. V. (2000) Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?
Schizophrenia Research, 41, 405–415.
Commissioners in Lunacy for England and Wales (1909) Annual Report. London: HMSO.
Craig T. J. & Lin S. P. (1981) Cancer and mental illness. Comprehensive Psychiatry, 22, 404–410.
Goldacre M., Kurina L., Yeates D., et al (2000) Use of large medical databases to study associations between diseases. Quarterly Journal of Medicine, 93, 669–675.
Herrman H. E., Baldwin J. A. & Christie D. (1983) A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic. Psychological Medicine, 3, 581–593.
Holman C. D., Bass A. J., Rouse I. L., et al (1999) Population-based linkage of health records in Western Australia: development of a health services research linked database. Australian and New Zealand Journal of Public Health, 23, 453–459.
Kelly C. & McCreadie R. G. (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry, 156, 1751–1757.
Kendrick S. & Clarke J. (1993) The Scottish record linkage system. Health Bulletin, 51, 72–79.
McCreadie R. G. (2003) Diet, smoking and cardiovascular risk in peoplewith schizophrenia: descriptive study. British Journal of Psychiatry, 83, 534–539.
McGrath J. (1999) Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?
Schizophrenia Research, 40, 173–177.
Mortensen P. B. (1989) The incidence of cancer in schizophrenic patients. Journal of Epidemiology and Community Health, 43, 43–47.
Mortensen P. B. (1994) The occurrence of cancer in first admitted schizophrenic patients. Schizophrenia Research, 2, 185–194.
Mortensen P. B. & Juel K. (1993) Mortality and causes of death in first admitted schizophrenic patients. British Journal of Psychiatry, 63, 183–189.
Moskovitz R. A. (1978) Seasonality in schizophrenia. Lancet, i, 664.
Office of Population Censuses and Surveys (1975) Classification of Surgical Operations (3rd revision). London: OPCS.
Scheflen A. E. (1951) Malignant tumours in the institutionalized psychotic population. Archives of Neurology and Psychiatry, 66, 145–155.
Van der Mei I. A. F., Ponsonby A. L. & Dwyer T. (2003) Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case–control study. BMJ, 327, 316–320.
World Health Organization (1978) International Statistical Classification of Diseases and Related Health Problems (ICD-9). Geneva: WHO.
Yovel G., Sirota P., Mazeh D., et al (2000) Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking. Brain, Behavior, and Immunity, 14, 153–169.